OncoSec intends to use proceeds from the offering for general corporate purposes, including clinical trial expenses and research and development expenses.
The Cancer Consortium
Cancer News & Information Center
OncoSec intends to use proceeds from the offering for general corporate purposes, including clinical trial expenses and research and development expenses.